1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 4-diphenylacetoxy-1,1-dimethylpiperidinium in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (4-diphenylacetoxy-1,1-dimethylpiperidinium) | Trials (4-diphenylacetoxy-1,1-dimethylpiperidinium) | Recent Studies (post-2010) (4-diphenylacetoxy-1,1-dimethylpiperidinium) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 446 | 1 | 52 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Howell, RE; Kovalsky, MP; Laemont, KD | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 4-diphenylacetoxy-1,1-dimethylpiperidinium
Article | Year |
---|---|
Methoctramine induces nonspecific airway hyperresponsiveness in vivo.
Topics: Aerosols; Albuterol; Animals; Arachidonic Acid; Atropine; Bronchial Hyperreactivity; Bronchoconstriction; Diamines; Drug Synergism; Gallamine Triethiodide; Guinea Pigs; Histamine; Male; Muscarinic Antagonists; Ovalbumin; Parasympatholytics; Piperazines; Piperidines; Platelet Activating Factor; Propranolol; Receptors, Muscarinic | 1994 |